Dallas, TX 的 澱粉樣變性 臨床試驗
9 項針對 澱粉樣變性 的研究正在 Dallas（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
招募中觀察性研究
- Research Site, Dallas
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
招募中3 期
- Clinical Trial Site, Dallas
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
招募中3 期
- Clinical Trial Site, Dallas
DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
招募中觀察性研究
- Clinical Trial Site, Dallas
Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
招募中觀察性研究
- University of Texas Southwestern Medical Center, Dallas
Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
招募中1/2 期
- UT Southwestern Medical Center, Dallas
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
招募中3 期
- University of Texas Southwestern, Dallas
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
招募中3 期
- Baylor Scott & White Research Institute, Dallas
- University of Texas Southwestern Medical Center, Dallas
Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study
招募中觀察性研究
- UT Southwestern Medical Center, Dallas
其他城市的 澱粉樣變性 試驗
- Boston, MA11 項研究
- New York City, NY10 項研究
- Rochester, MN10 項研究
- Philadelphia, PA7 項研究
- Houston, TX6 項研究
- Durham, NC6 項研究
- Baltimore, MD6 項研究
- St. Louis, MO6 項研究
- Portland, OR6 項研究
- Chicago, IL5 項研究
- Nashville, TN5 項研究
- Cleveland, OH5 項研究
Dallas 的其他研究
- 乳癌55 項研究
- 非小細胞肺癌52 項研究
- 轉移性癌症42 項研究
- 心臟衰竭42 項研究
- 癌症（所有類型）37 項研究
- 前列腺癌36 項研究
- 大腸直腸癌33 項研究
- 肥胖症30 項研究
- 卵巢癌28 項研究
- 肺癌27 項研究
- 膀胱癌27 項研究
- 子宮內膜癌24 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。